A limited supply of cannabis in the U.S. means those resources have to be divvied up carefully. For Cronos Group, that means keeping its medical and recreational marijuana operations in completely different verticals, CEO Michael Gorenstein told Cheddar. That ensures patients’ needs are prioritized over those of recreational users. “If you think about building a town, and you have a limited amount of building supplies, we want to make sure that we’re building a hospital before we’re building the bar,” he said. Canada-based Cronos Group started trading on the NASDAQ on Tuesday, making it the first marijuana company to list on a major U.S. market. “It’s a big milestone not just for us but for the entire industry,” said Gorenstein. “[It] just continues to show the acceptance that the cannabis industry is getting.” And the industry does seem to be growing at break-neck speed. Arcview, a leading researcher of the cannabis market, stated in a [recent report](https://arcviewgroup.com/product/5th-edition/) that the industry brought in $9.7 billion in sales in 2017, and that number could grow to over $25 billion by 2021. For the full interview, [click here](https://cheddar.com/videos/inside-the-first-cannabis-company-to-list-on-nasdaq).

Share:
More In Business
Daytime-Only Dining First Watch Restaurants CEO on Nasdaq Debut, Pandemic Rebound
Restaurant chain First Watch made its public debut on Nasdaq under the ticker symbol FWRG. CEO and President Chris Tomasso joined Cheddar’s "Opening Bell" to discuss the IPO launch and how the chain distinguishes itself from others in the restaurant space with its daytime-only concept. Tomasso also talked about how his company was able to adapt to the pandemic and retain employees as eateries reopened.
Waymo, Cruise Get Fees Permit From California’s DMV for Driverless Rideshares
Autonomous car companies Waymo and Cruise are one step closer to offering driverless ridesharing in California after receiving approval from the state's DMV to begin charging fees for their services. Both companies still need approval from the California Public Utilities Commission before offering rides to the public.
Markets Rebound on Potential Covid-19 Pill from Merck
Futures rebounded this morning in reaction to positive news from Merck that its covid-19 treatment pill is 50 percent effective at preventing hospitalizations and death. It comes after a rocky month on Wall Street, which saw all the major averages post their worst months in over a year. Chris Vecchio, Senior Analyst, at DailyFX joined Wake Up with Cheddar for more.
Load More